NCT04191447View on ClinicalTrials.gov

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

PHASE3UnknownINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

October 31, 2023

Conditions
Asthma
Interventions
DRUG

Flamboyant 200/12

Flamboyant 200/12 capsule

DRUG

Budesonide / Formoterol 400/12

Budesonide / Formoterol 400/12 capsule

OTHER

Flamboyant 200/12 Placebo

Flamboyant 200/12 Placebo capsule

OTHER

Budesonide / Formoterol 400/12 Placebo

Budesonide / Formoterol 400/12 Placebo capsule

Trial Locations (1)

Unknown

RECRUITING

IMC Tatuí, Tatuí

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY

NCT04191447 - Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma | Biotech Hunter | Biotech Hunter